Bandingkan Harga & Kinerja Morenzo Abadi Perkasa Tbk. (ENZO) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Morenzo Abadi Perkasa Tbk. dan Tempo Scan Pacific Tbk.: Morenzo Abadi Perkasa Tbk. diperdagangkan di Rp69 (kapitalisasi pasar 147,05 M, volume 24 jam 8,6 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.520 (kapitalisasi pasar 11,18 T, volume 24 jam 613 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 76× kapitalisasi pasar Morenzo Abadi Perkasa Tbk., dan Morenzo Abadi Perkasa Tbk. lebih aktif diperdagangkan (8,6 jt vs 613 rb). Mana yang lebih baik tergantung tujuan investasimu.
| ENZO | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 147,05 M | 11,18 T |
Volume | 8,6 jt | 613 rb |
Lot | 85,96 rb | 6,13 rb |
Perputaran | 591,25 jt | 1,54 M |
Harga Rata-rata | 68,78 | 2.511,52 |
Nilai Transaksi | 591,25 jt | 1,54 M |
Harga Ekuilibrium Indikatif | 69 | 2.520 |
Volume Ekuilibrium Indikatif | 4,14 rb | 17 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Morenzo Abadi Perkasa Tbk.
PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.
Selengkapnya di halaman ENZO →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
